Gut health biotechnology group Microba has landed some big names in its Series B founding round, with Alex Waislitz’s Thorney Investments, Perennial Value and Sydney investment firm Alium Capital backing the 18-month old venture
Microba raised $10 million in the round, with chief executive Blake Wills telling Street Talk he was pleased with the calibre of investors willing to back the young company.
Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Anthony Macdonald is a Chanticleer columnist. He is a former Street Talk co-editor and has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies. Connect with Anthony on Twitter. Email Anthony at a.macdonald@afr.com
